IBEX (NASDAQ:IBEX – Get Free Report) posted its earnings results on Thursday. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.20, FiscalAI reports. IBEX had a return on equity of 29.98% and a net margin of 7.34%. The firm had revenue of $175.23 million for the quarter, compared to the consensus estimate of $169.31 million.
Here are the key takeaways from IBEX’s conference call:
- IBEX reported 16% revenue growth to a record $175.2 million in Q1, its seventh consecutive quarter of double-digit growth. Adjusted EBITDA rose 29% to a record $25.2 million, and adjusted EBITDA margin expanded 150 basis points to 14.4%.
- The company raised FY2027 guidance: revenue is now expected to be $720 million–$735 million, up from $700 million–$715 million, while adjusted EBITDA guidance increased to $96 million–$99 million from $90 million–$94 million. Management expects 50–70 basis points of full-year margin improvement and year-over-year EBITDA improvement in each remaining quarter, though not at Q1’s pace.
- New client wins and expansion with existing customers both supported growth: recent new-logo cohorts accounted for about 50% of Q1 revenue growth, while revenue from the top five, top 10, and top 25 clients grew 14%, 13%, and 18%, respectively. Management said client retention remains above 99%.
- IBEX said its Sierra partnership is generating demand for combined AI-agent and human-support offerings, including four AI-agent deals since the quarter and three additional verbal traditional BPO wins. In one example, an AI deployment reduced abandoned calls by more than 60% and helped IBEX win the client’s traditional call-center work.
IBEX Stock Performance
IBEX stock traded up $6.52 during midday trading on Friday, reaching $49.52. 414,464 shares of the stock were exchanged, compared to its average volume of 90,691. The company’s fifty day moving average is $43.00 and its 200-day moving average is $34.50. The firm has a market cap of $660.60 million, a PE ratio of 15.01 and a beta of 0.74. IBEX has a 52 week low of $25.94 and a 52 week high of $49.89.
Key Headlines Impacting IBEX
Here are the key news stories impacting IBEX this week:
- Positive Sentiment: IBEX raised its FY2027 revenue forecast to $720 million–$735 million, above the roughly $712.3 million consensus estimate. The company attributed the improved outlook in part to accelerating Sierra AI-agent deals. Ibex raises FY 2027 revenue outlook
- Positive Sentiment: First-quarter revenue grew 16% year over year to $175.2 million, topping the $169.3 million consensus estimate. EPS of $1.10 also beat the $0.90 estimate, indicating stronger-than-expected performance. IBEX: 3 Key Takeaways for Long-Term Investors
- Positive Sentiment: Wall Street Zen upgraded IBEX, adding a favorable analyst-rating signal, though the article listing did not specify the new rating. IBEX upgraded at Wall Street Zen
- Positive Sentiment: A Barron’s investor-community post highlighted IBEX reaching a new 52-week high and its AI-powered call-center business, reflecting positive market attention; this is commentary rather than a formal company announcement. A new 52-high in this market!? IBEX
Insiders Place Their Bets
In other IBEX news, CEO Robert Dechant sold 5,000 shares of the firm’s stock in a transaction on Friday, September 25th. The shares were sold at an average price of $45.02, for a total value of $225,100.00. Following the completion of the transaction, the chief executive officer directly owned 257,011 shares of the company’s stock, valued at $11,570,635.22. This trade represents a 1.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mingzhe Zhuang sold 5,522 shares of the business’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $40.10, for a total transaction of $221,432.20. Following the transaction, the director owned 2,813 shares of the company’s stock, valued at $112,801.30. This trade represents a 66.25% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 97,465 shares of company stock worth $3,882,291. Company insiders own 3.40% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on the company. Robert W. Baird lifted their price target on IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a research report on Monday, September 28th. Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, October 12th. Finally, Wall Street Zen upgraded IBEX from a “buy” rating to a “strong-buy” rating in a research note on Saturday. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $42.00.
Check Out Our Latest Stock Analysis on IBEX
IBEX Company Profile
IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services.
The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.
Read More
- Five stocks we like better than IBEX
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
